Aperture
Startup rounds since 2012 with a Aperture investor on the board, and the firm's own fund filings.
Raises
45
since 2012
Unannounced
0
no announcement found, of those filed since 2025
Funds
4
fund filings under the firm's name
Rounds
- Venus Concept Inc.$1.1M
- Neuros Medical, Inc.$20M
- Venus Concept Inc.$2M
- Neuros Medical, Inc.$8.23M
- Venus Concept Inc.$6.72M
- Venus Concept Inc.$4.74M
- Venus Concept Inc.$12.3M
- Recover Together, Inc.$60M
- Recover Together, Inc.$200K
- Recover Together, Inc.$27M
- Recover Together, Inc.$11M
- Neuros Medical, Inc.$37M
- Neuros Medical, Inc.$2.2M
- AristaMD, Inc.$1M
- Neuros Medical, Inc.$2.39M
- AristaMD, Inc.$1.5M
- AristaMD, Inc.$1.5M
- AristaMD, Inc.$500K
- AristaMD, Inc.$1M
- Chronic Care Management, Inc.$1.99M
- AristaMD, Inc.$1M
- AristaMD, Inc.$1M
- AristaMD, Inc.$2.9M
- AristaMD, Inc.$1M
- Neuros Medical, Inc.$22.6M
- Recover Together, Inc.$350K
- AristaMD, Inc.$1M
- AristaMD, Inc.$4.6M
- Spirox, Inc.$44.9M
- AristaMD, Inc.$1.38M
- AristaMD, Inc.$1.38M
- Avedro Inc$16.5M
- Ebh Holding Company, Inc.$2M
- Essia Health, Inc.$2.5M
- Ebh Holding Company, Inc.$3M
- Channel Medsystems, Inc.$23.9M
- Spirox, Inc.$18.5M
- Avedro Inc$13.7M
- Ebh Holding Company, Inc.$4M
- Channel Medsystems, Inc.$6M
- Mimosa Medical, Inc.$445K
- AristaMD, Inc.$2.14M
- Vericare Management Inc$1.8M
- Xlumena, Inc.$20.6M
- Avedro Inc$26M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2024 | 1 | — |
| 2023 | 2 | — |
| 2022 | 2 | — |
| 2021 | 6 | — |
| 2020 | 3 | — |
| 2019 | 4 | — |
| 2018 | 5 | — |
| 2017 | 4 | — |
| 2016 | 3 | — |
| 2015 | 9 | — |
| 2014 | 5 | — |
| 2012 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Aperture Opportunity Fund, L.P. | 15 Apr 2021 | Open-ended | — |
| Aperture Venture Partners V, L.P. | 6 Dec 2018 | Open-ended | — |
| Aperture Venture Partners IV, L.P. | 25 Nov 2015 | Open-ended | — |
| Aperture Venture Partners III, L.P. | 31 Dec 2014 | $100M | $49.2M |
Listed because a Aperture fund's filing names a director of each company. A name match is not a verified identity.